Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
===================================================================================================================================================

* Jun Gong
* Alexander Chehrazi-Raffle
* Srikanth Reddi
* Ravi Salgia